跳至主要内容
临床试验/NCT05812300
NCT05812300已完成不适用

The Clinical Study of Injection of Freshly Prepared HA35 for Treatment Gingivitis

Dove Medical Press Ltd1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2023年6月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
20
试验地点
1
主要终点
Measurement of gum discomfort

研究概览

简要总结

Preliminary clinical studies have confirmed that injection of freshly prepared HA35 can reduce symptoms and signs of gingivitis or periodontitis. This clinical study is a prospective repeated experiments. The purpose of this study was to verify the effectiveness of HA35 injection therapy.

详细描述

The previous studies showed that toothpastes containing the cosmetic grade raw material of the 35 kDa low molecular hyaluronan fragment HA35 significantly reduced symptoms and signs of gingivitis or periodontitis. In this study, patients with mild to moderate periodontitis suffering from symptoms and signs, including discomfort and swelling and bleeding of periodontal tissue, were treated by intrapocket injection of freshly manufactured hyaluronan fragment HA35. This study is an repeat clinical study comparing pre- and posttreatment effects similar to others.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Healthy condition and with a clinical diagnosis of mild to moderate gingivitis.
  • Male or female volunteers aged 18-60 years.
  • Gingival Index (GI) from 1 to 2 (0= Normal gingiva; 1= Mild inflammation - slight change in color and slight edema but no bleeding on probing; 2= Moderate inflammation - redness, edema and glazing, bleeding on probing)

排除标准

  • Healthy condition and with a clinical diagnosis of severe gingivitis.
  • Pregnant or lactating females.
  • Be concomitantly participating in another clinical study.
  • History of any allergic reaction to HA.
  • To treat the gingivitis with any other medication/mouthwashes in the period of the study.

研究组 & 干预措施

HA35 local injection of Periodontal Pocket group

Experimental

The tissue-permeable 35 kDa low molecular hyaluronan fragment HA35 was freshly manufactured using pharmaceutical grade hyaluronidase PH20 injection (State Drug Administration H31022111) and joint cavity HA injection (State Drug Administration H20174089) mixed at room temperature for 20 min.

干预措施: Freshly manufactured 35 kDa hyaluronan fragment (Drug)

结局指标

主要结局

Measurement of gum discomfort

时间窗: 7 days

Each patient rated their gingival discomfort or itching on a scale of 0 to 10. 0 means "no", and 10 means "the most".

Measurement of gum redness and swelling

时间窗: 7 days

The physician used the numbers 0-10 to rate the intensity of gingival redness and swelling in the subject. 0 means "no"; 10 means "highest".

Measurement of probe gingival bleeding

时间窗: 7 days

The physician used the numbers 0-10 to rate the extent to which the subject's probe gums were bleeding. A score of 0 indicated "no" and 10 indicated "the most"

次要结局

未报告次要终点

研究者

申办方类型
Network
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验